HeartWare Buys CircuLite In Deal That Could Reach $350M
HeartWare said it has paid $12 million in cash to settle CircuLite's outstanding debt, in addition to paying $18 million in HeartWare common stock. The other potential $220 million is contingent upon possible regulatory milestone and revenue-based payments, according to HeartWare's statement.
The deal gives Massachusetts-based HeartWare control...
To view the full article, register now.